Drug Development in Dementia

Dementia is a progressive, irreversible decline in cognition that, by definition, impacts on a patient pre-existing level of functioning. The clinical syndrome of dementia has several aetiologias of which Alzheimer’s disease (AD) is the most common. Drug development in AD is based on evolving pathophysiological theory. Disease modifying approaches include the targeting of amyloid processing, aggregation of tau, insulin signaling, neuroinflammation and neurotransmitter dysfunction, with efforts thus far yielding abandoned hopes and ongoing promise. Reflecting its dominance on the pathophysiological stage the amyloid cascade is central to many of the emerging drug therapies.

 

  • Neurotransmitter based
  • Neuroprotective
  • Anti-inflammatory
  • Cognitive enhancers

Related Conference of Drug Development in Dementia

July 09-11, 2018

Annual Congress on Mental Health

Conference Venue: Holiday Inn – Marne La Vallée Paris, France
July 25-26, 2018; Pacific Gateway Hotel at Vancouver Airport, British Columbia,

5Th World Congress on Mental Health and Well-being

Vancouver, Canada
August 27-28, 2018

5th International conference on Stress, Mental Health and Dementia

Boston, Massachusetts, USA
August 27-28, 2018

World Summit on Stress, Mindfulness and Philosophy

Boston, Massachusetts, USA
September 19-20, 2018

30th World Summit on Psychology, Psychiatry and Psychotherapy

San Diego, California, USA
October 01-02, 2018

30th World Psychiatrists and Psychologists Meet

Osaka, Japan
October 18-20, 2018

International Conference & Expo on Clinical Psychology


Amsterdam, Netherlands
November 19-20, 2018 | Paris, France

Annual Congress on Psychiatric & Mental Health Nursing

November 26-27, 2018

World Summit on Psychiatry, Mental Health Nursing and Healthcare

Los Angeles, California, USA
November 26-27, 2018

International Conference on Applied Psychology, Psychiatry and Mental Health

Los Angeles ,California, USA
March 29-30, 2019

31st American Psychiatry and Psychology Congress

Orlando, Florida, USA

Drug Development in Dementia Conference Speakers

Recommended Sessions

Related Journals

Are you interested in